posted on 2024-09-05, 22:38authored bySteven Robins
This paper compares and contrasts the cultures of activism and illness and treatment experiences of UK
and South African AIDS activists. By the 1990s AIDS public health discourse in the UK, and elsewhere in
the West, was reconfiguring AIDS as a manageable chronic illness that could be treated much like
diabetes. By contrast, the introduction of anti-retroviral therapy (ART) in the South African public health
sector in 2000 was described using quasi-religious phrases and narratives: “the Lazarus effect” and “God’s
gift of life.” The paper is concerned with investigating these significant differences between Northern and
Southern experiences and responses to ARV treatment. It is specifically interested in the ways in which
relatively easy access to treatment in the UK has, in certain cases, contributed towards the
individualisation, medicalisation and “normalisation” of HIV/AIDS. For example, some of the UK
activists I interviewed claimed that the availability of ART through the NHS had “killed activism”. The
paper shows how the individualising and depoliticising medicalisation processes associated with NHS
treatment programmes stand in stark contrast to South Africa, where the ongoing legal and political
struggles for treatment access continue to strengthen and sustain collective forms of social activism and
mobilisation. The paper explores the implications of these strikingly different treatment contexts,
experiences and responses. These include differences in the availability and quality of treatment and health
services, infection and mortality rates, socio-economic profile of PWAs, political cultures of activism, and
contrasting government and activist responses to the pandemic. In sum, individualising and normalising
processes of “medicalisation” associated with the NHS are increasingly, it would seem, becoming
obstacles to collectivist forms of mobilisation.
History
Publisher
IDS
Citation
Robins, S. (2005) From "medical miracles" to normal(ised) medicine : AIDS treatment, activism and citizenship in the UK and South Africa. Working paper series, 252. Brighton: IDS.